Evidence map›Paper›PMID 28285434›Full record

ArticleAIDS and behavior2017

Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment.

Heidi M Crane, Mary E McCaul, Geetanjali Chander, Heidi Hutton, Robin M Nance, Joseph A C Delaney, Joseph O Merrill, Bryan Lau, Kenneth H Mayer, Michael J Mugavero and 15 more

Abstract read
In one paragraph

Article in AIDS and behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed, 2 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 2 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Article
  19. Article
  20. Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 8 institutions in 1 country.

Heidi M CraneDepartment of Medicine, University of Washington, 325 9th Ave Box 359931, Seattle, WA, USA. hcrane@uw.edu.
Mary E McCaulDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA.
Geetanjali ChanderDepartment of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Heidi HuttonDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA.
Robin M NanceDepartment of Medicine, University of Washington, 325 9th Ave Box 359931, Seattle, WA, USA.
Joseph A C DelaneyDepartment of Epidemiology, University of Washington, Seattle, WA, USA.
Joseph O MerrillDepartment of Medicine, University of Washington, 325 9th Ave Box 359931, Seattle, WA, USA.
Bryan LauDepartment of Epidemiology, Johns Hopkins University, Baltimore, MD, USA.
Kenneth H MayerFenway Institute and Department of Medicine, Harvard Medical School, Boston, MA, USA.
Michael J MugaveroDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Matthew MimiagaFenway Institute and Division of Psychiatry, Harvard Medical School, Boston, MA, USA.
James H WilligDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Greer A BurkholderDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Daniel R DrozdDepartment of Medicine, University of Washington, 325 9th Ave Box 359931, Seattle, WA, USA.
Rob J FredericksenDepartment of Medicine, University of Washington, 325 9th Ave Box 359931, Seattle, WA, USA.
Karen CropseyDepartment of Psychiatry, University of Alabama at Birmingham, Birmingham, AL, USA.
Richard D MooreDepartment of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Jane M SimoniDepartment of Psychology, University of Washington, Seattle, WA, USA.
W Christopher MathewsDepartment of Medicine, University of California at San Diego, San Diego, CA, USA.
Joseph J EronDepartment of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Sonia NapravnikDepartment of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Katerina ChristopoulosDepartment of Medicine, University of California at San Francisco, San Francisco, CA, USA.
Elvin GengDepartment of Medicine, University of California at San Francisco, San Francisco, CA, USA.
Michael S SaagDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Mari M KitahataDepartment of Medicine, University of Washington, 325 9th Ave Box 359931, Seattle, WA, USA.
University of Washington · USJohns Hopkins University · USUniversity of Alabama at Birmingham · USUniversity of California, San Francisco · USUniversity of North Carolina at Chapel Hill · USFenway Health · USHarvard University · USUniversity of California, San Diego · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Latesha Ellen Elopre · 1988 to 2026
$84.1M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)U01AA020793 · NIAAA · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., LAU, BRYAN · 2011 to 2020
$5.8M
Integration of Evidence-based Alcohol Interventions into HIV CareU01AA020802 · NIAAA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CROPSEY, KAREN L, MUGAVERO, MICHAEL J · 2011 to 2020
$4.2M
1/4 Alcohol Research Consortium in HIV-Administrative Core (ARCH-AC)U24AA020801 · NIAAA · JOHNS HOPKINS UNIVERSITY · PI CHANDER, GEETANJALI, MCCAUL, MARY E · 2011 to 2021
$3.5M
NIAAA NIH HHS U01 AA020793NIAAA NIH HHS U01 AA020802NIAAA NIH HHS U24 AA020801NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI094189NIAID NIH HHS R24 AI067039
6 · The paper itself

Abstract

Hazardous alcohol use is associated with detrimental health outcomes among persons living with HIV (PLWH). We examined the prevalence and factors associated with hazardous alcohol use in the current era using several hazardous drinking definitions and binge drinking defined as ≥5 drinks for men versus ≥4 for women. We included 8567 PLWH from 7 U.S. sites from 2013 to 2015. Current hazardous alcohol use was reported by 27% and 34% reported binge drinking. In adjusted analyses, current and past cocaine/crack (odd ratio [OR] 4.1:3.3-5.1, p < 0.001 and OR 1.3:1.1-1.5, p < 0.001 respectively), marijuana (OR 2.5:2.2-2.9, p < 0.001 and OR 1.4:1.2-1.6, p < 0.001), and cigarette use (OR 1.4:1.2-1.6, p < 0.001 and OR 1.3:1.2-1.5, p < 0.001) were associated with increased hazardous alcohol use. The prevalence of hazardous alcohol use remains high in the current era, particularly among younger men. Routine screening and targeted interventions for hazardous alcohol use, potentially bundled with interventions for other drugs, remain a key aspect of HIV care.

Indexed as

AdultAlcohol DrinkingAlcoholismAnti-HIV AgentsBinge DrinkingCigarette SmokingCocaine-Related DisordersCrack CocaineFemaleHIV InfectionsHumansMaleMarijuana UseMiddle AgedOdds RatioPrevalenceAnti-HIV AgentsCrack CocaineAlcohol useHepatitis CHIVSubstance use

Identifiers

PMID28285434
PMCPMC5628735
OpenAlexW2592327440

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.